Skip to content
MarketScale
‹ Back to IndustriesHealthcare

HEAT WAVE IN JAPAN – BRUTAL AND DEADLY

An ongoing heat wave in southern Japan has killed 14 people as of Tuesday, July 17. The heat wave is striking at the worst possible time, as the country is dealing with the aftermath of horrific floods and landslides, killing 210 people last week. Record-High Temperatures Make Rescue Operations Difficult According to the World Meteorological Organization, a heat wave…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

An ongoing heat wave in southern Japan has killed 14 people as of Tuesday, July 17. The heat wave is striking at the worst possible time, as the country is dealing with the aftermath of horrific floods and landslides, killing 210 people last week.

Record-High Temperatures Make Rescue Operations Difficult

According to the World Meteorological Organization, a heat wave is when temperatures are at least five degrees greater than the average temperature for more than five consecutive days. In Japan, current temperatures are between four to seven degrees Celsius higher than usual.

In some locations, temperatures reached a remarkable high of 39 degrees Celsius––102 degrees Fahrenheit. Inland locations throughout Japan, including Kurashiki City in Okayama and Asakita Ward in Hiroshima, recorded the highest temperatures this year, according to Japan’s Meteorological Agency.

Heat-Related Illnesses Also Hit Aid Workers

With the brutal heat bearing down, thousands have sought medical treatment for heat stroke and heat exhaustion. Next to the victims, first responders, disaster relief workers and humanitarian aid workers are at great risk of heat-related illnesses. Also volunteers are affected. CNN reported that out of 33 people who sought medical help for heat-related conditions in Hiroshima, three were volunteers.

Extended working hours in times of crisis, limited access to drinking water and shade, lack of heat acclimation of workers as well as complicating personal health issues, such as diabetes or heart disease in first responders and other workers can all contribute to an elevated risk potential.

Breezer Mobile Cooling Products for Emergency Management

The mitigation of these risks is at the heart of every emergency response effort. Our innovative cooling products have proven to reduce hot temperatures and make conditions safer for everyone – even outdoors. They are perfect for triage areas, tents, medical treatment areas, displacement centers, relief areas, food lines and staging sites. Thanks to different air flow settings, our air coolers also dry damaged and wet spaces. With an electricity consumption similar to that of a rice cooker, our products can bring relief in disaster situations, such as this. For details, click here.

Read more at powerbreezer.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512